
Surgical Mesh Complication Lawyers
Have you suffered complications because of a defective surgical mesh product? Our defective medical device lawyers are currently investigating reports of serious problems caused by surgical mesh, especially hernia recurrence among people implanted with products like AlloDerm surgical mesh during hernia repair surgery. Our surgical mesh lawyers are also investigating problems related to the Mentor ObTape, the Bard Avaulta mesh, and other vaginal mesh products used to treat pelvic organ prolapse and urinary stress incontinence. Complications from surgical mesh include infections, erosions, abscess, and hernia recurrence.
In some cases, the complications seen with these surgical mesh products are the result of defective design, while others may be caused by improper placement of the device. In either case, you deserve compensation for your suffering. Our surgical mesh lawyers offer free case evaluations to the victims of AlloDerm, Mentor ObTape and Bard Avaulta injuries. If you were treated with AlloDerm, the Mentor ObTape, the Bard Avaulta mesh or a similar product, and experienced complications, you may be entitled to compensation. We urge you to contact one of our surgical mesh lawyers right away to protect your legal rights.
Hernia Recurrence Related to Surgical Mesh
Surgical mesh products like AlloDerm consist of a polymeric, biologic or metallic screen intended for implant to reinforce soft tissue or bone where weakness exists. Such mesh is typically used in surgery for the repair, reconstruction, or substitution of tissue, commonly in hernia repair surgical procedures.
Between 2007 and 2009, the US Food & Drug Administration (FDA) received 29 adverse event reports associated with 30 hernia mesh products in 30 patients from 20 hospitals. The most frequently reported device problems were:
- Mesh explanted due to recall (6 reports)
- Ring breakage (4 reports)
- Mesh tear (4 reports)
- Defective mesh (3 reports)
- Mesh perforation (3 reports)
- Adhesion issue (2 reports)
- Mesh erosion (2 reports)
Of these, 18 patients required additional surgery; five suffered an infection; and there were four reports of abscess.
One 2008 study of 70 hernia surgery patient found that AlloDerm’s overall complication rate was 24 percent. Of the AlloDerm patients who experienced complications, there was one rejection, two infections, and 14 hernia recurrences.
Complications from Vaginal Mesh
Mentor ObTape, the Bard Avaulta mesh and similar devices have been linked to a variety of complications including infections, erosions, and even injury to nearby organs. Vaginal mesh injuries are exceedingly painful, and even after additional procedures to correct problems, women who suffer such complications may not fully recover.
Evidence has been accumulating for some time now that the use of vaginal mesh to correct pelvic prolapse or to treat urinary incontinence is putting women at risk of serious complications. In October 2008, the FDA even warned that transvaginal placement of surgical mesh had been linked to hundreds of serious and painful injuries.
According to the agency, in the three years prior to the issuance of its alert, nine surgical mesh manufacturers had submitted more than 1000 reports of vaginal mesh complications that included erosion through vaginal epithelium, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence. The FDA said that bowel, bladder, and blood vessel perforations have also been reported. In some cases, vaginal scarring and mesh erosion led to significant discomfort and pain, significantly decreasing the patient’s quality of life.
Legal Help for Victims of Surgical Mesh Complications
If you suffered a serious complication following treatment with a surgical mesh product like AlloDerm, the Mentor ObTape or the Bard Avaulta mesh, you may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. To find out how we can help you get the justice you deserve, please fill out our online form or call 1 800 LAW INFO (1-800-529-4636) today.